ANXA2 can modify various pathways involved in pathophysiological processes, including tumor cell invasion, metastasis, bleeding disorders, angiogenesis, and induction of inflammatory factor expression (28, 29, 30, 31, 32, 33). Here, ANXA2 is linked to hemorrhagic disease.